Literature DB >> 9033270

Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?

G S Pinkus1, J L Pinkus, E Langhoff, F Matsumura, S Yamashiro, G Mosialos, J W Said.   

Abstract

Immunohistochemical localization of human fascin, a distinct 55-kd actin-bundling protein, was determined for a wide variety of lymphoid tissues (364 specimens total). In non-neoplastic tissues, reactivity was highly selective and localized predominantly in dendritic cells. In the thymus, this protein was distinctly localized to medullary dendritic cells. In reactive nodes, interdigitating reticulum cells of T zones, cells in subcapsular areas, and cells of the reticular network were reactive, with variable reactivity observed for follicular dendritic cells. Splenic dendritic cells of the white pulp and sinus-lining cells of the red pulp were reactive. Endothelial cells of all tissues exhibited variable reactivity. Lymphoid cells, myeloid cells, and plasma cells were uniformly nonreactive. In the peripheral blood, only dendritic (veiled) cells were reactive for fascin. A striking finding was observed for cases of Hodgkin's disease (total 187 cases). In all cases of nodular sclerosis (132), mixed cellularity (34), lymphocyte depletion (2), and unclassified types (5), all or nearly all Reed-Sternberg cells and variants were immunoreactive for fascin. Neoplastic cells exhibited strong diffuse cytoplasmic staining and frequently assumed dendritic shapes, particularly in the nodular sclerosis type, producing an interdigitating meshwork or syncytial network of cells. In cases of mixed cellularity type, neoplastic cells generally appeared more discrete. In all 14 cases of nodular lymphocyte predominance type, L&H variants were nonreactive. By contrast, neoplastic lymphoid cells of only 24 of 156 (15%) other lymphoid neoplasms (127 B cell, 27 T cell, and two null cell evaluated) were reactive for fascin. Fascin represents a highly effective marker for detection of certain dendritic cells in normal and neoplastic tissues, is an extremely consistent marker for Reed-Sternberg cells and variants of Hodgkin's disease (except L&H types), and may be helpful to distinguish between Hodgkin's disease and non-Hodgkin's lymphoma in difficult cases. The staining profile for fascin raises the possibility of a dendritic cell derivation, particularly an interdigitating reticulum cell, for the neoplastic cells of Hodgkin's disease, notably in nodular sclerosis type. However, as fascin expression may be induced by Epstein-Barr virus infection of B cells, the possibility that viral induction of fascin in lymphoid or other cell types must also be considered in Epstein-Barr virus-positive cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9033270      PMCID: PMC1858289     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  60 in total

Review 1.  The dendritic cell system and its role in immunogenicity.

Authors:  R M Steinman
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

2.  Cultured Reed-Sternberg cells HDLM-1 and KM-H2 can be induced to become histiocytelike cells. H-RS cells are not derived from lymphocytes.

Authors:  S M Hsu; S S Xie; P L Hsu
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

3.  Identification of an Mr 70,000 antigen associated with Reed-Sternberg cells and interdigitating reticulum cells.

Authors:  P L Hsu; S M Hsu
Journal:  Cancer Res       Date:  1990-01-15       Impact factor: 12.701

4.  The distinct surface of human blood dendritic cells, as observed after an improved isolation method.

Authors:  P S Freudenthal; R M Steinman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

5.  The never-ending controversies in Hodgkin's disease.

Authors:  S M Hsu
Journal:  Blood       Date:  1990-04-15       Impact factor: 22.113

6.  The immunophenotype of Reed-Sternberg cells. A study of 50 cases of Hodgkin's disease using fixed frozen tissues.

Authors:  B A Agnarsson; M E Kadin
Journal:  Cancer       Date:  1989-06-01       Impact factor: 6.860

Review 7.  Hodgkin's disease revisited: Reed-Sternberg cells as natural hybridomas.

Authors:  J G Sinkovics
Journal:  Crit Rev Immunol       Date:  1991       Impact factor: 2.214

8.  Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin's disease. Results of Southern blot analysis and polymerase chain reaction.

Authors:  J W Said; A F Sassoon; I P Shintaku; P J Kurtin; G S Pinkus
Journal:  Am J Pathol       Date:  1991-02       Impact factor: 4.307

9.  Demonstration of light chain mRNA in Hodgkin's disease.

Authors:  K Hell; J H Pringle; M L Hansmann; J Lorenzen; P Colloby; I Lauder; R Fischer
Journal:  J Pathol       Date:  1993-10       Impact factor: 7.996

10.  Immunophenotypes of Reed-Sternberg cells: a study of 19 cases of Hodgkin's disease in plastic-embedded sections.

Authors:  T T Casey; S J Olson; J B Cousar; R D Collins
Journal:  Blood       Date:  1989-12       Impact factor: 22.113

View more
  39 in total

1.  High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.

Authors:  A van den Berg; L Visser; S Poppema
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  A Hodgkin's disease cell line, KM-H2, shows biphenotypic features of dendritic cells and B cells.

Authors:  K Uehira; R Amakawa; T Ito; T Uehira; Y Ozaki; T Shimizu; M Fujimoto; M Inaba; S Fukuhara
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 3.  The role of actin bundling proteins in the assembly of filopodia in epithelial cells.

Authors:  Seema Khurana; Sudeep P George
Journal:  Cell Adh Migr       Date:  2011 Sep-Oct       Impact factor: 3.405

4.  Nodular pattern of bone marrow infiltration: frequent finding in immunosuppression-related EBV-associated large B-cell lymphomas.

Authors:  Deborah W Sevilla; Erin M Weeden; Suzy Alexander; Vundavalli V Murty; Bachir Alobeid; Govind Bhagat
Journal:  Virchows Arch       Date:  2009-10-06       Impact factor: 4.064

5.  Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.

Authors:  Stephan Sudowe; Sabine Dominitzki; Evelyn Montermann; Matthias Bros; Stephan Grabbe; Angelika B Reske-Kunz
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

6.  Fascin1 promotes cell migration of mature dendritic cells.

Authors:  Yoshihiko Yamakita; Fumio Matsumura; Michael W Lipscomb; Po-chien Chou; Guy Werlen; Janis K Burkhardt; Shigeko Yamashiro
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

7.  Fascin expression in human embryonic, fetal, and normal adult tissue.

Authors:  Fa-Ren Zhang; Li-Hua Tao; Zhong-Ying Shen; Zhuo Lv; Li-Yan Xu; En-Min Li
Journal:  J Histochem Cytochem       Date:  2007-11-12       Impact factor: 2.479

8.  Fascin expression in dendritic cells and tumor epithelium in thymoma and thymic carcinoma.

Authors:  Junichiro Sato; Masachika Fujiwara; Tomohiro Kawakami; Ayumi Sumiishi; Seiji Sakata; Atsuhiko Sakamoto; Atsushi Kurata
Journal:  Oncol Lett       Date:  2011-08-17       Impact factor: 2.967

9.  Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.

Authors:  Ines Schwering; Andreas Bräuninger; Verena Distler; Julia Jesdinsky; Volker Diehl; Martin-Leo Hansmann; Klaus Rajewsky; Ralf Küppers
Journal:  Mol Med       Date:  2003 Mar-Apr       Impact factor: 6.354

10.  Expression of fascin in thyroid neoplasms: a novel diagnostic marker.

Authors:  Guang Chen; Fa-Ren Zhang; Jiang Ren; Li-Hua Tao; Zhong-Ying Shen; Zhuo Lv; Shi-Jiang Yu; Bing-Fei Dong; Li-Yan Xu; En-Min Li
Journal:  J Cancer Res Clin Oncol       Date:  2008-03-15       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.